Cisplatin
- Product NDC
- 0703-5747
- 11-digit product format
- 007035747
- Labeler code
- 0703
- Product ID
- 0703-5747_adf5773e-9095-4cb4-a90f-72cbf82f4493
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisplatin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA074656
- Marketing category
- ANDA
- Marketing start
- 2000-06-01
- Substance
- CISPLATIN
- Active strength
- 50 mg/50mL
- Pharmacologic classes
- Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cisplatin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CISPLATIN | 50 mg/50mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Q20Q21Q62J |
| Rxcui | 309311 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0703-5747-11 | Cisplatin | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 12 |
| 0703-5747-11 | Cisplatin | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | | 12 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CISPLATIN | ACTIVE INGREDIENT | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| CISPLATIN | ACTIVE MOIETY | Q20Q21Q62J | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0703-5747 | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20221001_a440f077-46f6-4688-a209-65bce38d1c92.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-5747-11 | 00703574711 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-5747-11) / 50 mL in 1 VIAL, MULTI-DOSE | 2000-06-01 | 0000-00-00 | No | No | Current |